N. Lynn Henry

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

M. Dowsett, Torsten O. Nielsen, Roger A’Hern et al. · JNCI Journal of the National Cancer Institute · 2011 · 2K citations · Full text

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

Lisa A. Carey, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2015 · 429 citations · Full text

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

N. Lynn Henry, Faouzi Azzouz, Zereunesay Desta et al. · Journal of Clinical Oncology · 2012 · 379 citations · Full text

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer

Dawn L. Hershman, Joseph M. Unger, Heather Greenlee et al. · JAMA · 2018 · 276 citations · Full text

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

N. Lynn Henry, Jon T. Giles, Dennis C. Ang et al. · Breast Cancer Research and Treatment · 2007 · 232 citations

Breast Oncology, Medicine, Prospective Characterization +8